Caring at the transition: success and financial barriers of fidaxomicin discharge prescriptions for inpatients with Clostridioides difficile infection
This retrospective cohort study evaluated the proportion of inpatients initiated and successfully discharged on fidaxomicin for Clostridioides difficile infection. Nearly, all patients (96.4%; 27/28) were able to obtain fidaxomicin to complete their treatment course, although there was variability i...
Saved in:
Main Authors: | Ellen Earle, Jigar Mehta, Alexis Blecher, Matthew Shou Lun Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2025-01-01
|
Series: | Antimicrobial Stewardship & Healthcare Epidemiology |
Online Access: | https://www.cambridge.org/core/product/identifier/S2732494X24004844/type/journal_article |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fidaxomicin: A Novel Agent for the Treatment of Clostridium difficile Infection
by: George G Zhanel, et al.
Published: (2015-01-01) -
Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in Ireland
by: Anke van Engen, et al.
Published: (2015-05-01) -
Clinical and Economic Consequences of Vancomycin and Fidaxomicin for the Treatment of Clostridium difficile Infection in Canada
by: Monika Wagner, et al.
Published: (2014-01-01) -
Virulence Factors of Clostridioides (Clostridium) difficile Linked to Recurrent Infections
by: Laura Tijerina-Rodríguez, et al.
Published: (2019-01-01) -
Gastroenterological Surgery and Management of Clostridioides difficile Infection: A Review
by: Tomonori Takano, et al.
Published: (2025-01-01)